{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:06:40Z","timestamp":1761919600248},"reference-count":43,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1138,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1111\/j.1600-0404.2012.01703.x","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T22:38:55Z","timestamp":1342823935000},"page":"242-250","source":"Crossref","is-referenced-by-count":11,"title":["The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study"],"prefix":"10.1155","volume":"127","author":[{"given":"P.","family":"Jennum","sequence":"first","affiliation":[{"name":"Department of Clinical Neurophysiology, Faculty of Health Sciences; Danish Center for Sleep Medicine, Center for Healthy Aging, Glostrup Hospital, University of Copenhagen; Copenhagen; Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Frederiksen","sequence":"additional","affiliation":[{"name":"Department of Neurology; Glostrup Hospital, University of Copenhagen; Glostrup; Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wanscher","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurophysiology, Faculty of Health Sciences; Danish Center for Sleep Medicine, Center for Healthy Aging, Glostrup Hospital, University of Copenhagen; Copenhagen; Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kjellberg","sequence":"additional","affiliation":[{"name":"Danish Institute for Health Services Research; Copenhagen; Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,7,20]]},"reference":[{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0001|ane1703-cit-0001","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.53.3.473","article-title":"Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey","volume":"53","author":"Sorensen","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0002|ane1703-cit-0002","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006036.pub2","article-title":"Multidisciplinary rehabilitation for adults with multiple sclerosis","volume":"18","author":"Khan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0003|ane1703-cit-0003","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001430.pub2","article-title":"Corticosteroids for treating optic neuritis","volume":"24","author":"Vedula","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0004|ane1703-cit-0004","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1537-2995.2005.00581.x","article-title":"Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review","volume":"45","author":"Fergusson","year":"2005","journal-title":"Transfusion"},{"issue":"Suppl 2","key":"10.1111\/j.1600-0404.2012.01703.x-BIB0005|ane1703-cit-0005","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s10198-006-0365-y","article-title":"Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis","volume":"7","author":"Kobelt","year":"2006a","journal-title":"Eur J Health Econ"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0006|ane1703-cit-0006","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jnnp.2006.090365","article-title":"Costs and quality of life of patients with multiple sclerosis in Europe","volume":"77","author":"Kobelt","year":"2006b","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0007|ane1703-cit-0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1191\/1352458504ms967oa","article-title":"A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study","volume":"10","author":"Morales-Gonzales","year":"2004","journal-title":"Mult Scler"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0008|ane1703-cit-0008","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.31.10.1316","article-title":"The cost-effectiveness of multiple sclerosis rehabilitation: a model","volume":"31","author":"Feigenson","year":"1981","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0009|ane1703-cit-0009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0404.1997.tb00208.x","article-title":"Economic consequences of multiple sclerosis for Canadians","volume":"95","author":"Asche","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0010|ane1703-cit-0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/jnnp.64.4.444","article-title":"Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium)","volume":"64","author":"Carton","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0011|ane1703-cit-0011","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00019053-199915030-00003","article-title":"The economics of multiple sclerosis. Distribution of costs and relationship to disease severity","volume":"15","author":"Grudzinski","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0012|ane1703-cit-0012","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/bmj.320.7247.1474","article-title":"Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast","volume":"320","author":"Bryant","year":"2000","journal-title":"BMJ"},{"issue":"Suppl 2","key":"10.1111\/j.1600-0404.2012.01703.x-BIB0013|ane1703-cit-0013","first-page":"S191","article-title":"A cost evaluation of multiple sclerosis","volume":"6","author":"Battaglia","year":"2000","journal-title":"J Neurovirol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0014|ane1703-cit-0014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1468-1331.2001.00169.x","article-title":"Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden","volume":"8","author":"Henriksson","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0015|ane1703-cit-0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1524-4733.2002.51001.x","article-title":"The value of economic modeling studies in the evaluation of treatment strategies for multiple sclerosis","volume":"5","author":"Detournay","year":"2002","journal-title":"Value Health"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0016|ane1703-cit-0016","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1191\/1352458505ms1211oa","article-title":"Economic evaluation of Avonex (interferon beta-Ia) in patients following a single demyelinating event","volume":"11","author":"Iskedjian","year":"2005","journal-title":"Mult Scler"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0017|ane1703-cit-0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1468-1331.2004.00950.x","article-title":"A prospective study of the financial costs of multiple sclerosis at different stages of the disease","volume":"12","author":"Orlewska","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0018|ane1703-cit-0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.euroneuro.2011.05.001","article-title":"The socioeconomic consequences of multiple sclerosis: a controlled national study","volume":"22","author":"Jennum","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0019|ane1703-cit-0019","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Optic neuritis study group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0020|ane1703-cit-0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archopht.1992.01080150029020","article-title":"The optic neuritis treatment trial. Implications for clinical practice. Optic neuritis study group","volume":"110","author":"Beck","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0021|ane1703-cit-0021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0303-8467(02)00039-2","article-title":"The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver","volume":"104","author":"Gusev","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0022|ane1703-cit-0022","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0404.1997.tb00233.x","article-title":"Serial Gadolinium-enhanced MRI in untreated patients with acute optic neuritis: implications for natural history","volume":"96","author":"Frederiksen","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0023|ane1703-cit-0023","first-page":"45","article-title":"The natural history of optic neuritis","volume":"3","author":"Atkins","year":"2006","journal-title":"Rev Neurol Dis"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0024|ane1703-cit-0024","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2188\/jea.JE20080085","article-title":"Activities of daily living, functional capacity, and life satisfaction of subacute myelo-optico-neuropathy patients in Japan","volume":"19","author":"Kamei","year":"2009","journal-title":"J Epidemiol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0025|ane1703-cit-0025","first-page":"1017","article-title":"The national eye institute visual function questionnaire: experience of the ONTT. Optic neuritis treatment trial","volume":"41","author":"Cole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0026|ane1703-cit-0026","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0027|ane1703-cit-0027","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1600-0404.1991.tb04713.x","article-title":"MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis","volume":"83","author":"Frederiksen","year":"1991","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0028|ane1703-cit-0028","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1403494810390729","article-title":"The danish multiple sclerosis registry","volume":"39","author":"Bronnum-Hansen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0029|ane1703-cit-0029","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0030|ane1703-cit-0030","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An Introduction to the Bootstrap","author":"Efron","year":"1993"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0031|ane1703-cit-0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0046-8177(73)80043-7","article-title":"Strategy for cost-effective laboratory testing","volume":"4","author":"Werner","year":"1973","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0032|ane1703-cit-0032","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/jnnp.66.2.256a","article-title":"Utilisation and costs of profession care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium)","volume":"66","author":"Forbes","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0033|ane1703-cit-0033","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0303-8467(02)00051-3","article-title":"Quality of life and cost of multiple sclerosis","volume":"104","author":"Miltenburger","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"issue":"Suppl 1","key":"10.1111\/j.1600-0404.2012.01703.x-BIB0034|ane1703-cit-0034","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1007\/s10198-005-0289-y","article-title":"Economic evidence in multiple sclerosis: a review","volume":"5","author":"Kobelt","year":"2004","journal-title":"Eur J Health Econ"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0035|ane1703-cit-0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0003-9993(03)00614-2","article-title":"The cost and benefits of employment: a qualitative study of experiences of persons with multiple sclerosis","volume":"85","author":"Johnson","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"issue":"Suppl 1","key":"10.1111\/j.1600-0404.2012.01703.x-BIB0036|ane1703-cit-0036","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1468-1331.2005.01193.x","article-title":"Cost of multiple sclerosis in Europe","volume":"12","author":"Kobelt","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0037|ane1703-cit-0037","first-page":"17","article-title":"Health economic issues in MS","volume":"13","author":"Kobelt","year":"2006","journal-title":"Int MS J"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0038|ane1703-cit-0038","doi-asserted-by":"crossref","first-page":"799","DOI":"10.18553\/jmcp.2007.13.9.799","article-title":"Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs-pharmacy and medical benefit spending from 2004 through 2007","volume":"13","author":"Kunze","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0039|ane1703-cit-0039","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10072-009-0015-0","article-title":"Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon beta-1b","volume":"30","author":"Lazzaro","year":"2009","journal-title":"Neurol Sci"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0040|ane1703-cit-0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1352458508099477","article-title":"The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated","volume":"15","author":"Marrie","year":"2009","journal-title":"Mult Scler"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0041|ane1703-cit-0041","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1352458509352196","article-title":"Social consequences of multiple sclerosis (1): early pension and temporary unemployment-a historical prospective cohort study","volume":"16","author":"Pfleger","year":"2010","journal-title":"Mult Scler"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0042|ane1703-cit-0042","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2012.01703.x-BIB0043|ane1703-cit-0043","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1600-0404.1996.tb00515.x","article-title":"Serial MRI, VEP, SEP and biothesiometry in acute optic neuritis: value of baseline results to predict the development of new lesions at 1\u00a0year follow up","volume":"93","author":"Frederiksen","year":"1996","journal-title":"Acta Neurol Scand"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2012.01703.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2012.01703.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:51:00Z","timestamp":1671540660000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2012.01703.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,20]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2012.01703.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,20]]}}}